Health News Explained

The FDA granted accelerated approval to Voceryq, a plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis.

• Health News Tribe Team
• November 3, 2026

In a 432-patient phase III China trial, izalontamab brengitecan improved median PFS over chemotherapy, with more severe treatment-related side effects.

• Health News Tribe Team
• October 29, 2026

Interim phase III analyses found lower proteinuria with povetacicept, ravulizumab and sefaxersen; longer-term kidney-function data are still pending.

• Health News Tribe Team
• October 26, 2026

A Norwegian study links antibodies targeting DNA repair proteins with childhood cancer and reports they were present in some children years before diagnosis.

• Health News Tribe Team
• October 15, 2026

A 32-patient UK trial reported no bowel cancer recurrences after almost three years following pembrolizumab before surgery.

• Health News Tribe Team
• October 11, 2026

The FDA approved once-daily pritelivir for HSV lesions in immunocompromised patients whose infections have not responded to other treatments.

• Health News Tribe Team
• October 11, 2026

A study in eLife links the protein LMOD1 to early muscle stem cell differentiation and interaction with SIRT1 in mouse cells and injured muscle.

• Health News Tribe Team
• October 8, 2026

A U.S. registry study found nonstroke neurologic events were as common as strokes after HeartMate 3 implantation and were associated with lower survival.

• Health News Tribe Team
• October 8, 2026

A MedPage Today opinion article reviews a year of tracking Robert F. Kennedy Jr.’s health claims and argues they undermine trust in public health.

• Health News Tribe Team
• October 4, 2026

A Science review synthesizes evidence that sex chromosomes influence immunity, cancer, aging and other diseases, alongside hormones.

• Health News Tribe Team
• October 4, 2026